We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Rapid7
RPD
$773M
| $4.38M | 0.01% |
58,749
-4,119
| -7% | -$342K |
|
1477
Supernus Pharmaceuticals
SUPN
$2.77B
| $4.37M | 0.01% |
166,723
+4,521
| +3% | +$126K |
|
1478
Coca-Cola Consolidated
COKE
$12.8B
| $4.36M | 0.01% |
151,090
+1,520
| +1% | +$41.8K |
|
|
AYX
1479
DELISTED
Alteryx Inc
AYX
| $4.36M | 0.01% |
52,589
-2,910
| -5% | -$308K |
|
1480
Vertiv
VRT
$105B
| $4.36M | 0.01% |
217,855
-2,094
| -1% | -$42.3K |
|
1481
Iovance Biotherapeutics
IOVA
$2.87B
| $4.34M | 0.01% |
137,150
-8,039
| -6% | -$333K |
|
1482
Lantheus
LNTH
$6.59B
| $4.34M | 0.01% |
203,100
-74
| -0% | -$1.34K |
|
1483
AZZ Inc
AZZ
$4.54B
| $4.34M | 0.01% |
86,164
-1,832
| -2% | -$92.7K |
|
|
DHC
1484
Diversified Healthcare Trust
DHC
$2.14B
| $4.34M | 0.01% |
907,243
+9,022
| +1% | +$41.5K |
|
|
OSH
1485
DELISTED
Oak Street Health, Inc.
OSH
| $4.33M | 0.01% |
79,724
+62,608
| +366% | +$3.48M |
|
1486
National Vision
EYE
$1.81B
| $4.33M | 0.01% |
98,680
-10,346
| -9% | -$493K |
|
|
ENDP
1487
DELISTED
Endo International plc
ENDP
| $4.32M | 0.01% |
583,317
-8,871
| -1% | -$71.9K |
|
1488
Matthews International
MATW
$739M
| $4.31M | 0.01% |
108,946
+1,417
| +1% | +$49.9K |
|
1489
AXIS Capital
AXS
$7.55B
| $4.3M | 0.01% |
86,727
-4,463
| -5% | -$224K |
|
|
CATM
1490
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $4.29M | 0.01% |
110,687
+134
| +0.1% | +$5.21K |
|
|
TUP
1491
DELISTED
Tupperware Brands Corporation
TUP
| $4.29M | 0.01% |
162,597
+1,248
| +0.8% | +$38.9K |
|
|
ENV
1492
DELISTED
ENVESTNET, INC.
ENV
| $4.29M | 0.01% |
59,434
-7,079
| -11% | -$550K |
|
1493
Enova International
ENVA
$6.29B
| $4.29M | 0.01% |
120,890
+2,369
| +2% | +$70.9K |
|
|
LMNX
1494
DELISTED
Luminex Corp
LMNX
| $4.28M | 0.01% |
134,210
+2,105
| +2% | +$62.4K |
|
|
ECOL
1495
DELISTED
US Ecology, Inc.
ECOL
| $4.27M | 0.01% |
102,591
+860
| +0.8% | +$33.5K |
|
|
HA
1496
DELISTED
Hawaiian Holdings, Inc.
HA
| $4.27M | 0.01% |
159,952
+6,916
| +5% | +$164K |
|
1497
Encore Capital Group
ECPG
$2.13B
| $4.26M | 0.01% |
105,907
+229
| +0.2% | +$8.13K |
|
1498
Fulgent Genetics
FLGT
$527M
| $4.26M | 0.01% |
44,058
+8,966
| +26% | +$926K |
|
1499
Griffon
GFF
$4.86B
| $4.24M | 0.01% |
155,929
+4,367
| +3% | +$108K |
|
1500
Herbalife
HLF
$1.29B
| $4.24M | 0.01% |
95,479
-4,960
| -5% | -$245K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.